# US 2021/0330981 A1 · Apparatus with enhanced stimulation waveforms

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330981 A1
- Document ID: US20210330981A1
- Status: Published application
- Kind: A1
- Application number: 17/372,095
- Filed: 2021-07-09
- Published: 2021-10-28
- Earliest claimed: 2016-02-19
- Assignees: Nalu Medical, Inc.
- Applicants: Nalu Medical, Inc.
- Inventors: Lakshmi Narayan MISHRA; James C. MAKOUS; Lee Fason HARTLEY; Daniel M. PIVONKA; J. Christopher FLAHERTY
- Web page: https://patentgrep.com/patent/US20210330981A1

## CPC

- A61N 1/36146: {specified by the stimulation parameters}
- A61N 1/0556: {Cuff electrodes}
- A61N 1/0558: {Anchoring or fixation means therefor}
- A61N 1/36062: {Spinal stimulation}
- A61N 1/36071: {Pain}
- A61N 1/36075: {Headache or migraine}
- A61N 1/36178: {Burst or pulse train parameters}
- A61N 1/37205: {Microstimulators, e.g. implantable through a cannula}
- A61N 1/37229: {Shape or location of the implanted or external antenna}
- A61N 1/36171: {Frequency}
- A61N 1/36175: {Pulse width or duty cycle}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A medical apparatus for a patient comprises an implantable system. The implantable system comprises a first implantable device comprising: at least one implantable functional element configured to deliver stimulation energy to tissue of the patient; and an implantable controller configured to provide a stimulation waveform to the at least one implantable functional element, the stimulation waveform comprising one or more stimulation parameters. The apparatus is configured to randomly vary at least one of the one or more stimulation parameters. Methods of providing stimulation energy with randomly varying stimulation parameters are also provided.

## Claims

### Claim 1

A method for treating a patient, the method comprising:
delivering therapeutic stimulation energy to a tissue of the patient, the therapeutic stimulation energy being based on a therapeutic stimulation waveform,
wherein the therapeutic stimulation waveform comprises bursts of trains of pulses,
wherein each train comprises a series of pulses and each burst comprises a series of trains,
each train having a train-on period from a beginning of a first pulse of said train to an end of a last pulse of said train, wherein there is a train-off quiescent period between an end of one train and a beginning of a next train, and
each burst having a burst-on period from a beginning of a first pulse of a first train of said burst to an end of a last pulse of a last train of said burst, wherein there is a burst-off quiescent period between an end of one burst and a beginning of a next burst, and
wherein the therapeutic stimulation waveform comprises a plurality of waveform parameters including the train-on period, the train-off quiescent period, the train-off quiescent period, the burst-on period, and the burst-off quiescent period, said waveform parameters being selected to effect treatment of the patient.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the train-on period is between 1 μsec and 100 msec.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the train-off period is between 1 μsec and 100 msec.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the burst-on period is between 8 msec and 12 msec.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the burst-off period is between 8 msec and 18 msec.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform comprises a series of monophasic pulses.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform comprises a biphasic pulse.

### Claim 8 (depends on 1)

The method according to claim 1, wherein one or more of the waveform parameters of the therapeutic stimulation waveform are selected to effect treatment of the patient while reducing paresthesia.

### Claim 9 (depends on 8)

The method according to claim 8, further comprising randomly varying one or more therapeutic stimulation parameters to reduce paresthesia.

### Claim 10 (depends on 8)

The method according to claim 8, wherein the therapeutic stimulation waveform comprises an inter-pulse gap that is varied.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the inter-pulse gap is varied randomly.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform comprises an inter-pulse gap with a first duration and an inter-train period with a second duration, and wherein the first duration is less than the second duration.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform comprises an inter-pulse gap with a duration between 1 μsec and 1 second.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the therapeutic stimulation waveform comprises an inter-pulse gap with a duration between 1 μsec and 100 μsec.

### Claim 15 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform comprises an inter-phase gap with a duration between 10 μsec and 30 μsec.

### Claim 16 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform comprises pulses with a pulse width between 1 μsec and 10 msec.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform comprises a high frequency carrier signal modulated with a low frequency envelope.

### Claim 18 (depends on 1)

The medical apparatus according to claim 1, wherein the therapeutic stimulation waveform comprises an envelope with a shape selected from the group consisting of: cosine; cosine-squared; sine; square; rectangle; triangle; symmetric triangle; asymmetric triangle; trapezoid; sawtooth; ramp; linear ramp; and combinations thereof.

### Claim 19 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform comprises a duty cycle between 0.1% and 99%.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the therapeutic stimulation waveform comprises a duty cycle between 1% and 25%.

### Claim 21 (depends on 1)

The method according to claim 1, wherein the apparatus is configured to randomly vary one or more therapeutic stimulation parameters.

### Claim 22 (depends on 21)

The method according to claim 21, further comprising randomly varying one or more therapeutic stimulation parameters based on a probability distribution.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the probability distribution comprises a distribution selected from the group consisting of: a uniform distribution; an arbitrary distribution; a gamma distribution; a normal distribution; a log-normal distribution; a Pareto distribution; a Gaussian distribution; a Poisson distribution; a Rayleigh distribution; a triangular distribution; a statistic distribution; and combinations thereof.

### Claim 24 (depends on 22)

The method according to claim 22, wherein the one or more therapeutic stimulation parameters are randomly varied to elicit a neurostimulation effect selected from the group consisting of: synchronized superthreshold neuronal activation; stochastic activation; sub-paresthesia neuronal stimulation; and combinations thereof.

### Claim 25 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform comprises pulses with a pulse width between 10 μsec and 300 μsec.

### Claim 26 (depends on 25)

The method according to claim 25, wherein the therapeutic stimulation waveform comprises pulses with a pulse width between 30 μsec and 90 μsec.

### Claim 27 (depends on 1)

The method according to claim 1, wherein the train-on period has a duration between 700 μsec and 1.1 msec.

### Claim 28 (depends on 1)

The method according to claim 1, wherein the train-off period between trains has a duration between 900 μsec and 1.7 msec.

### Claim 29 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform is configured to treat pain.

### Claim 30 (depends on 29)

The method according to claim 29, wherein the therapeutic stimulation waveform is configured to treat pain selected from the group consisting of: back pain; joint pain; neuropathic pain; tennis elbow; muscle pain; shoulder pain; chronic, intractable pain of the back; chronic intractable pain of the lower limbs; unilateral pain; bilateral pain; neuropathic groin pain; perineal pain; phantom limb pain; complex regional pain syndrome; failed back surgery syndrome; cluster headaches; migraines; inflammatory pain; arthritis; abdominal pain; pelvic pain; and combinations thereof.

### Claim 31 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation waveform is configured to treat a disease or disorder selected from the group consisting of: chronic pain; acute pain; migraine; cluster headaches; urge incontinence; overactive bladder; fecal incontinence; bowel disorders; tremor; obsessive compulsive disorder; depression; epilepsy; inflammation; tinnitus; high blood pressure; heart failure; carpal tunnel syndrome; sleep apnea; obstructive sleep apnea; dystonia; interstitial cystitis; gastroparesis; obesity; mobility issues; arrhythmia; rheumatoid arthritis; dementia; Alzheimer's disease; eating disorder; addiction; traumatic brain injury; chronic angina; congestive heart failure; muscle atrophy; inadequate bone growth; post-laminectomy pain; liver disease; Crohn's disease; irritable bowel syndrome; erectile dysfunction; kidney disease; peripheral vascular disease; diabetic neuropathy; a condition associated with diabetes; peripheral diabetic neuropathic pain; painful diabetic peripheral neuropathy; peripheral vascular disease; peripheral arterial disease; peripheral artery disease; cardiac autonomic neuropathy; diabetic autonomic neuropathy; diabetic sensory neuropathy; diabetic motor neuropathy; diabetic sensorimotor neuropathy; diabetic muscular atrophy; diabetic neurovascular disease; and combinations thereof.

### Claim 32 (depends on 1)

The method according to claim 1, wherein one or more of the waveform parameters are selected to effect treatment of the patient while minimizing an undesired condition of the patient in response to the therapeutic stimulation energy.

### Claim 33 (depends on 32)

The method according to claim 32, wherein the undesired condition comprises paresthesia.

### Claim 34 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation energy is generated and delivered by at least one implantable functional element of an implantable system.

### Claim 35 (depends on 34)

The method according to claim 34, further comprising positioning the at least one implantable functional element of the implantable system at or near the tissue of the patient.

### Claim 36 (depends on 35)

The method according to claim 35, wherein the at least one implantable functional element comprises at least one electrode.

### Claim 37 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation energy is delivered to tissue selected from the group consisting of: spinal tissue, spinal cord tissue, spinal cord nerves, spinal cord ganglia, tissue associated with the spinal cord, nerves associated with the spinal cord, ganglia associated with the spinal cord, tissue in the spinal canal, nerves in the epidural space, the posterior spinal nerve root, the dorsal root, dorsal root ganglion, pre-ganglionic tissue on the posterior spinal nerve root, post-ganglionic tissue on the posterior spinal nerve root, the dorsal ramus, grey ramus communicans, white ramus communicans, ventral ramus, motor nerves, peripheral nerves, the tibial nerve, sensory fibers that lead to the tibial nerve, the occipital nerve, the sphenopalatine ganglion, the sacral nerve, the pudendal nerve, the hypoglossal nerve, the vagus nerve, the renal nerve, brain tissue, the thalamus, muscles of the tongue, cardiac tissue, the anal sphincter, the heart, the liver, the kidney, an artery, a vein, a bone, a muscle, and combinations thereof.

### Claim 38 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation energy is delivered to tissue of or associated with a spinal cord to treat pain with reduced paresthesia to treat pain.

### Claim 39 (depends on 1)

The method according to claim 1, wherein the therapeutic stimulation energy is delivered to tissue of or associated with a peripheral nerve to treat pain with reduced paresthesia to treat pain.

### Claim 40

A method for treating a patient, the method comprising:
delivering therapeutic stimulation energy to tissue of or associated with a spinal cord of a patient, the therapeutic stimulation energy being based on a therapeutic stimulation waveform,
wherein the therapeutic stimulation waveform comprises bursts of trains of pulses,
wherein each train comprises a series of pulses and each burst comprises a series of trains,
each train having a train-on period from a beginning of a first pulse of said train to an end of a last pulse of said train, wherein there is a train-off quiescent period between an end of one train and a beginning of a next train, and
each burst having a burst-on period from a beginning of a first pulse of a first train of said burst to an end of a last pulse of a last train of said burst, wherein there is a burst-off quiescent period between an end of one burst and a beginning of a next burst, and
wherein the therapeutic stimulation waveform comprises a plurality of waveform parameters including the train-on period, the train-off quiescent period, the train-off quiescent period, the burst-on period, and the burst-off quiescent period, said waveform parameters being selected to treat pain of the patient with reduced paresthesia.

### Claim 41

A method for treating a patient, the method comprising:
delivering therapeutic stimulation energy to a tissue of or associated with a peripheral nerve of the patient, the therapeutic stimulation energy being based on a therapeutic stimulation waveform,
wherein the therapeutic stimulation waveform comprises bursts of trains of pulses,
wherein each train comprises a series of pulses and each burst comprises a series of trains,
each train having a train-on period from a beginning of a first pulse of said train to an end of a last pulse of said train, wherein there is a train-off quiescent period between an end of one train and a beginning of a next train, and
each burst having a burst-on period from a beginning of a first pulse of a first train of said burst to an end of a last pulse of a last train of said burst, wherein there is a burst-off quiescent period between an end of one burst and a beginning of a next burst, and
wherein the therapeutic stimulation waveform comprises a plurality of waveform parameters including the train-on period, the train-off quiescent period, the train-off quiescent period, the burst-on period, and the burst-off quiescent period, said waveform parameters being selected to treat pain of the patient with reduced paresthesia.
